Dress Code: Business Casual
Agenda: Click here for latest AGENDA
Robert (Bob) Broeze joined CMC Biologics in 2015 and serves as the Chief Business Officer, responsible for global sales and marketing. He has over 30 years of experience in the biopharmaceutical and contract manufacturing industries including positions as Senior VP, Business Development at Gallus Biopharmaceuticals, LLC (now Patheon Biologics) and Chief Commercial Officer and Chief Executive Officer at Laureate BioPharma. His technical expertise spans research, development, protein characterization, validation, testing and cGMP manufacture of biopharmaceutical products, from pilot to Phase III clinical and commercial scale with a strong emphasis on monoclonal antibody products for therapeutic and diagnostic use. He also held senior positions in R&D and operations at Purdue BioPharma L.P., Bard BioPharma L.P and at Cytogen Corporation. Bob is a graduate of Rensselaer Polytechnic Institute where he earned his BS and Ph.D. degrees.
Gustavo Mahler, PhD, joined CMC Biologics in 2008 as president. In 2010, he was named global Chief Operations Officer and in January, 2016 he became Chief Executive Officer. Prior to joining CMC Biologics, Gustavo worked for 15 years at Bayer in the United States, Europe and Latin America serving in various manufacturing and general management positions. He received his PhD in Biochemistry from the University of Buenos Aires, and he also has a Master of Business Administration degree from the University UNED of Madrid and an Executive Certification in Management from MIT Sloan.
Manager of the newly formed AGC Bioscience General Division. In that role he is responsible
for growth and business development. Kurata-san has 30 years of experience in the chemical
and contract manufacturing industries and has held several key executive positions, entrusted
with the responsibilities of designing and starting up several chemical plants, along with
developing new business and planning AGC’s semiconductor vertical. In addition, Kurata-san
held the position of President and Chief Executive Officer of AGC Chemicals, Americas for five
years. He successfully executed a turnaround for the once struggling organization. Kurata-san
is a graduate of Waseda University in Japan, and holds a B.Sc. and Master’s Degree in the field
of Chemical Engineering.
Eric Langer has over 25 years experience in biotechnology and life sciences strategic marketing management, market research, and publishing. He has held senior management and marketing positions at biopharmaceutical supply companies. He has published and authored many books and reports on topics in Biotechnology, China and India biotech, Large-scale BioManufacturing, etc. He teaches at Johns Hopkins University marketing management, biotech marketing, services marketing, and marketing in a regulated environment. In 1989 he co-founded BioPlan Associates, Inc. to provide market analysis, and strategy to biotech and healthcare organizations.
Patricia Seymour, M.B.A., CSCP is a Senior Consultant with BioProcess Technology Consultants and has over 20 years of experience in the biotechnology industry. Her expertise spans the development and commercialization spectrum, including biologics and small molecule development and manufacturing, supply chain strategy and management, and operations leadership. Her current activities include developing overall CMC strategies for diverse product pipelines, developing and implementing supply chain strategies, managing outsourced process development and manufacturing activities from drug substances through to distribution, steering clients through CMC regulatory requirements, and overall CMC operations including project management. Prior to joining BioProcess Technology Consultants, Ms. Seymour was Senior Director, Global Investigational Supply Operations at Millennium Pharmaceuticals, Inc., where she worked with other senior leaders to develop and implement CMC strategies including outsourcing. She was previously Director of Business Development at Covance Biotechnology Services (now part of the FujiFilm Diosynth) where her responsibilities included negotiating contact manufacturing projects. As Senior Director, Corporate Development at Collaborative BioAlliance she was instrumental in launching the new contract manufacturing business unit. Before Collaborative, Ms. Seymour held research and development positions at ImmunoGen, Dana Farber and Sloan Kettering. Ms. Seymour received her B.S. from Villanova University and her M.B.A. from Boston University. Ms. Seymour is also Certified Supply Chain Professional (APICS).
John Moscariello joined CMC Biologics in 2014 and serves as the Vice President, Process Development. Prior to joining CMC Biologics, he held director-level positions at Amgen focused on process development and characterization, clinical and commercial technology transfer, and process validation.
John has a PhD in Chemical and Biological Engineering from the University of Wisconsin-Madison and a Bachelors of Chemical Engineering from the University of Delaware.
Thermo Fisher Scientific Inc. is the world leader in serving science, with revenues of $17 billion and more than 50,000 employees in 50 countries. Our mission is to enable our customers to make the world healthier, cleaner and safer. We help our customers accelerate life sciences research, solve complex analytical challenges, improve patient diagnostics and increase laboratory productivity. Through our premier brands – Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific and Unity Lab Services – we offer an unmatched combination of innovative technologies, purchasing convenience and comprehensive support.
For more information, please visit thermofisher.com.